A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma
Hanjie Yi(Nanchang University), Da-Jun Yang
Cited by 70
Related Papers
Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma
|Cancer Medicine|2020|49
Gefitinib induces non‑small cell lung cancer H1650 cell apoptosis through downregulating tumor necrosis factor‑related apoptosis‑inducing ligand expression levels
|Oncology Letters|2018|1
Novel antagonist APG-115 targets MDM2-p53 to induce p53-mediated apoptosis and radiosensitization in colorectal cancer
|Clinical and Experimental Medicine|2026|0